Status:
COMPLETED
Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-64 years
Phase:
PHASE2
Brief Summary
Compare once daily vs on demand treatment in men with erectile dysfunction. Treatment of mild to moderate erectile dysfunction with 10 mg vardenafil p.o. over 24 weeks + 4 weeks wash-out: A: once da...
Eligibility Criteria
Inclusion
- Males 18-64 years of age
- Mild or mild to moderate ED (defined as \>15 and \<21 score points according to the Erectile Function Domain Score from IIEF as assessed at the randomisation visit)
- History of at least one of the following conditions: Diabetes mellitus type 2, hypertension, peripheral arterial occlusive disease
- Stable, heterosexual relationship for more than six months
Exclusion
- Primary hypoactive sexual desire
- History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
- Nitrate therapy.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT00786253
Start Date
October 1 2005
End Date
January 1 2007
Last Update
October 28 2014
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Tübingen, Baden-Württemberg / 277, Germany, 72076
2
München, Bayern / 280, Germany, 81925
3
Regensburg, Bayern / 280, Germany, 93053
4
Weiden, Bayern / 280, Germany, 92637